SUBSCRIBE

Breaking News on Contract Research, Manufacturing & Clinical Trials

Hot Topics > Globalisation

Globalisation

Globalisation

When national businesses become global operations… With the industry sourcing more raw materials and services from around the world and distributing its products in new markets, companies are adapting their business processes to suit a more complex global operating environment.

Tigermed Envy? WuXi may be eyeing a launch on Shenzhen exchange

14-May-2015 - With WuXi pushing full steam ahead in its bid to go private, one expert says that the company may be envious of a competing CRO -- Hangzhou Tigermed, which is...

Chinese drugmaker looks West in market expansion deal with ELC Group

22-Apr-2015 - Understanding international regulatory demands, manufacturing standards and overcoming cultural barriers are key for Asian drugmakers looking to enter Western markets, says market access CRO ELC Group.

Quintiles pushes further into LatAm with Argentinian hospital alliance

17-Apr-2015 - Quintiles on Thursday announced the selection of Hospital Italiano of Buenos Aires, Argentina, as the company’s first “Prime Site” in Latin America, adding to the company’s network of investigative sites...

WuXi offers more details on the complexity of CRO, CMO competition

15-Apr-2015 - Competition in the notoriously tight-lipped CRO (contract research organization) and CMO (contract manufacturing organization) industries is getting fiercer as outsourcing picks up, though that hasn’t stopped one Chinese company from...

'Unjustified' ban of GVK-tested drugs has damaged India, says Pharmexcil

08-Apr-2015 - The reputation of Indian clinical trials has been damaged by the “unjustified” suspension of medicines tested by GVK Biosciences, Pharmexcil says as it attacks the evidence submitted by French regulators.

AMRI sets sights on acquiring Indian API manufacturer, CEO says

11-Mar-2015 - Following its three acquisitions over the last year, AMRI is now looking to extend its footprint into India further with the acquisition of a FDA-approved API site, William Marth, president...

Exclusive interview

Preclinical prices improving says Huntingdon CEO; firm is mulling US capacity expansion

05-Mar-2015 - Higher capacity utilization is improving prices across the non-clinical research sector according to Huntingdon Life Sciences CEO Brian Cass, who told Outsourcing-pharma.com the preclinical CRO may add scale to US...

Patheon: Irix deal about US and Canadian customer demand for local APIs; all staff to be retained

05-Mar-2015 - Irix Pharmaceuticals will cater for North American customers’ desire for local supply according to Patheon, which says it plans to retain the API firm’s 180 staff.

Waters 2014: Global growth led by generic drugmakers in India

27-Jan-2015 - Sales of consumables and analytical tools grew 20% in India in 2014 due to demand from generic drugmakers, says Waters Corporation.

PPD adds cell-based assay services in Ireland to service EU demand

22-Jan-2015 - PPD is expanding its GMP services in Ireland to support regulatory requirements for the growing number of biopharmaceutical drugs in development.

Ocean rises for drug transportation due to cost and cold chain concerns

15-Jan-2015 - AstraZeneca and Baxter are opting to transport pharmaceuticals by ocean and land routes as costs and cold chain security drive a drop in air freight.

Shareholder nod for Medtronic and Covidien's $43bn 'strategic' merger

07-Jan-2015 - The $43bn (€36bn) megamerger between Medtronic and Covidien is one step closer after shareholders voted to approval the deal yesterday.

Cromos offers free clinical trials to cash-strapped small and mid-sized pharmas

18-Dec-2014 - Cromos Pharma has launched a free or reduced cost trial model to help small and mid-sized drugmakers overcome the funding Catch-22 that can derail development efforts.

News in brief

WuXi to bolster US presence with Boston and San Francisco offices

15-Dec-2014 - WuXi PharmaTech is increasing its presence in the US announcing the opening of offices on the East and West coast.

Europe's response "disproportionate" says GVK Biosciences

15-Dec-2014 - GVK Biosciences has called marketing authorisation withdrawals by various European regulators “disproportionate,” arguing that ECG results at centre of data manipulation investigation have no bearing on safety.

After AZ R&D exit, CMOs anxious to keep pharma in the country

11-Dec-2014 - Pharma companies have called on the Swedish government to prevent manufacturing going the way of R&D and leaving the country, after AstraZeneca closed its research in Lund in 2012.

Meda cuts Recipharm contract: Swedish plant and jobs under threat

04-Dec-2014 - Meda has terminated a manufacturing contract with Recipharm which says a facility in Sweden and up to 60 jobs could be at threat.

CROs encouraged by new NIH policy calling for single IRB to speed trials

04-Dec-2014 - CRO industry group ACRO has welcomed a US NIH draft policy promoting use of a single IRB for site reviews per institute-backed multi-centre study, arguing that the approach would accelerate trials...

From CPHI India 2014

Indian manufacturing problems spur growth... for testing companies

03-Dec-2014 - SGS has doubled testing capacity at its Mumbai facility, explaining that Indian API makers’ failure to invest in quality has been good for business.

Mabion extends agreement with Croatian CRO for Mabthera biosimilar study

01-Dec-2014 - The pace of recruitment is the biggest challenge in carrying out trials in Eastern Europe, says Mabion which has extended an agreement with local CRO Altiora for its biosimilar study.

German CMO looks to grow US biz through rise in SMEs and virtual pharma

24-Nov-2014 - Rottendorf is looking to break from being “the best kept secret in the CMO world” by targeting the thousands of virtual and SME pharma firms in the US, according to its CEO....

Exclusive interview

INC stock launches up almost 10% as CEO says business as usual

10-Nov-2014 - The IPO boom for CROs is kicking off with INC Research’s stock offering, which as of Friday afternoon saw a nearly 10% rise, meaning the company raised more than $150m.

China sets new requirements for hospitals running clinical trials

10-Nov-2014 - The Chinese authorities are supplementing their current regulations around clinical trials with new mandates for the hospitals that conduct the studies. 

news from cphi

CDMO strategic deals 'the new standard,' say Catalent and DPx, but big and small pharma demands differ

16-Oct-2014 - Strategic relationships with contract manufacturers are becoming the standard, but big and small pharma demands differ considerably according to the two largest CDMOs, DPx and Catalent.

Novotech moves into China with new Shanghai office after requests from US and EU customers

01-Oct-2014 - Australia’s largest clinical CRO Novotech has expanded its services into China with a new office in Shanghai.

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...